Related Experiment Video
Updated: Nov 20, 2025

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
Published on: December 17, 2019
Recent advances and discoveries in the mechanisms and functions of CAR T cells
Rebecca C Larson1,2, Marcela V Maus3,4
1Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA.
Abstract:
This Review discusses the major advances and changes made over the past 3 years to our understanding of chimeric antigen receptor (CAR) T cell efficacy and safety. Recently, the field has gained insight into how various molecular modules of the CAR influence signalling and function. We report on mechanisms of toxicity and resistance as well as novel engineering and pharmaceutical interventions to overcome these challenges. Looking forward, we discuss new targets and indications for CAR T cell therapy expected to reach the clinic in the next 1-2 years. We also consider some new studies that have implications for the future of CAR T cell therapies, including changes to manufacturing, allogeneic products and drug-regulatable CAR T cells.
Insights
Recent advances in chimeric antigen receptor (CAR) T cell therapy focus on efficacy and safety. New engineering strategies and targets are emerging for improved CAR T cell treatments and broader clinical applications.
Area of Science:
- Immunology
- Cellular Therapy
- Biotechnology
Background:
- Chimeric antigen receptor (CAR) T cell therapy has revolutionized cancer treatment.
- Understanding CAR T cell efficacy and safety has significantly evolved over the last three years.
Purpose of the Study:
- To review major advances in CAR T cell therapy over the past three years.
- To discuss new insights into CAR molecular modules, toxicity, resistance, and future clinical applications.
Main Methods:
- Literature review of recent scientific publications and clinical studies.
- Analysis of molecular mechanisms influencing CAR T cell signaling and function.
- Evaluation of novel engineering and pharmaceutical interventions.
Main Results:
- Gained insights into how CAR molecular modules affect T cell signaling and function.
- Identified mechanisms of CAR T cell toxicity and resistance.
- Highlighted novel interventions to overcome challenges in CAR T cell therapy.
Conclusions:
- The field is rapidly progressing with new targets and indications for CAR T cell therapy.
- Future directions include advancements in manufacturing, allogeneic products, and drug-regulatable CAR T cells.
Related Concept Videos
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Cell-mediated Immune Responses
Tumor Immunotherapy
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

